Peggy Pinkston | Seattle Genetics, Inc. |
Clay B. Siegall | Seattle Genetics, Inc. |
Darren S. Cline | Seattle Genetics, Inc. |
Roger D. Dansey | Seattle Genetics, Inc. |
Todd E. Simpson | Seattle Genetics, Inc. |
Salveen Richter | Goldman Sachs & Co. LLC |
Cory W. Kasimov | JPMorgan Securities LLC |
Kennen MacKay | RBC Capital Markets LLC |
Tazeen Ahmad | Bank of America Merrill Lynch |
Adnan Butt | Guggenheim Securities LLC |
Yatin Suneja | SunTrust Robinson Humphrey, Inc. |
Boris Peaker | Cowen & Co. LLC |
Andy Tsan-Yu Hsieh | William Blair & Co. LLC |
Gil Blum | Needham & Company |
Jason Zemansky | Barclays Capital, Inc. |
Good day, and welcome to the Seattle Genetics Second Quarter 2018 Financial Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn today's call over to Ms. Peggy Pinkston, Vice President, Investor Relations. Please go ahead, ma'am.